Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data
Gastrointestinal effects (nausea, diarrhea) are common initially
"At this point, I've lost the plot
Tablets could change that, but only if they are introduced responsibly, with the right education, support and expectations in place. Jason Murphy, Head of Pharmacy at Chemist4U The needle barrier holding people back GLP-1 injections have revolutionised weight loss, allowing those facing obesity and other weight-related conditions to take a meaningful step towards a healthier life
Compounded versions are not interchangeable with branded products because they have different levels of clinical validation and predictability